They include a sluggish metabolism, vitamin and mineral deficiencies, and even resistance to insulin
Rowlands J, Cruzat V, Carlessi R, Newsholme P
Achieving these stringent endpoints, as outlined in the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) consensus ( Research into mucosal healing has highlighted pathways involving interleukin-20 (IL-20), claudin-2 (CLDN2), and notoginsenoside R1 (NGR1) ( Figure 1 illustrates the differences in immune cell distribution within the intestinal crypts under homeostatic conditions compared with the inflammatory microenvironments of CD and UC
In one of those instances, an SMI patient who had diabetes and other comorbidities lost all the weight that was induced by their antipsychotic medication with the combination of a GLP-1 and metabolic psychiatry
In the STEP1 trial (100), Wilding et al
If you have been paying attention to cardiovascular medicine over the past decade, you have watched GLP-1 receptor agonists transform from diabetes drugs into one of the most powerful multi-system therapies in modern medicine